Literature DB >> 22797201

Late onset of subfoveal choroidal neovascularisation following cerebral radiotherapy.

Abdul-Jabbar Ghauri1, Mohammed Musadiq, Ying Sha, Samer Elsherbiny.   

Abstract

A report of choroidal neovascularisation (CNV) associated with radiation retinopathy. A 43-year-old Caucasian man presented with a 4-week history of sudden loss of central vision in the left eye, 8.5 years following radical radiotherapy for left tempero-parietal anaplastic astrocytoma. His visual acuity was 6/6 in the right eye and 6/60 in the left eye. Ophthalmoscopy of the left eye showed central macular pigmented area surrounded by subretinal fluid, haemorrhage and exudates. Fundus fluorescein angiography revealed left subfoveal CNV with surrounding macular oedema and peripheral retinal ischaemia. Radiation retinopathy associated CNV is a late ocular complication of cerebral radiotherapy. It should be investigated as a possible aetiology of severe visual loss in long-term survivors of cerebral tumours who have previously received radiotherapy.

Entities:  

Mesh:

Year:  2010        PMID: 22797201      PMCID: PMC3027866          DOI: 10.1136/bcr.05.2009.1825

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

Review 1.  Ophthalmic and adnexal complications of radiotherapy.

Authors:  Shane R Durkin; Daniel Roos; Braden Higgs; Robert J Casson; Dinesh Selva
Journal:  Acta Ophthalmol Scand       Date:  2007-05

2.  Subretinal neovascularization from the retina in radiation retinopathy.

Authors:  G T Boozalis; A P Schachat; W R Green
Journal:  Retina       Date:  1987       Impact factor: 4.256

3.  Atypical choroidal neovascularization in radiation retinopathy.

Authors:  Richard F Spaide; Natalie Borodoker; Viral Shah
Journal:  Am J Ophthalmol       Date:  2002-05       Impact factor: 5.258

4.  Late retinal complications of radiation therapy for nasal and paranasal malignancies: relationship between irradiated-dose area and severity.

Authors:  A Takeda; N Shigematsu; S Suzuki; M Fujii; T Kawata; O Kawaguchi; T Uno; H Takano; A Kubo; H Ito
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-06-01       Impact factor: 7.038

5.  Choroidal neovascular membrane in radiation retinopathy.

Authors:  Nilufer Berker; Ozlem Aslan; Cosar Batman; Ufuk Elgin; Seyhan Sonar Ozkan
Journal:  Clin Exp Ophthalmol       Date:  2006-08       Impact factor: 4.207

6.  Cephalic radiation and retinal vasculopathy.

Authors:  W M Amoaku; D B Archer
Journal:  Eye (Lond)       Date:  1990       Impact factor: 3.775

7.  Radiation retinopathy is treatable with anti-vascular endothelial growth factor bevacizumab (Avastin).

Authors:  Paul T Finger
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-03-15       Impact factor: 7.038

8.  Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.

Authors:  Edward R Laws; Ian F Parney; Wei Huang; Fred Anderson; Angel M Morris; Anthony Asher; Kevin O Lillehei; Mark Bernstein; Henry Brem; Andrew Sloan; Mitchel S Berger; Susan Chang
Journal:  J Neurosurg       Date:  2003-09       Impact factor: 5.115

Review 9.  Vascular endothelial growth factor: basic science and clinical progress.

Authors:  Napoleone Ferrara
Journal:  Endocr Rev       Date:  2004-08       Impact factor: 19.871

Review 10.  Radiation retinopathy: case report and review.

Authors:  Abha Gupta; Felipe Dhawahir-Scala; Amy Smith; Lorna Young; Steve Charles
Journal:  BMC Ophthalmol       Date:  2007-04-05       Impact factor: 2.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.